SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16117698
Source:
http://linkedlifedata.com/resource/pubmed/id/16117698
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0017601
,
umls-concept:C0028840
,
umls-concept:C0030705
,
umls-concept:C0034656
,
umls-concept:C0040233
,
umls-concept:C0087111
,
umls-concept:C0525227
pubmed:issue
4
pubmed:dateCreated
2005-8-24
pubmed:abstractText
The aim of this study was to compare the safety and intraocular pressure (IOP)- lowering efficacy of a fixed combination of brimonidine 0.2% and timolol 0.5% (fixed brimonidine/ timolol) versus each drug used as monotherapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9511091
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Quinoxalines
,
http://linkedlifedata.com/resource/pubmed/chemical/Timolol
,
http://linkedlifedata.com/resource/pubmed/chemical/brimonidine
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1080-7683
pubmed:author
pubmed-author:CheethamJanet KJK
,
pubmed-author:ChouConnieC
,
pubmed-author:Combigan Study Group
,
pubmed-author:CravenE RandyER
,
pubmed-author:SchiffmanRhettR
,
pubmed-author:WaltersThomas RTR
,
pubmed-author:WilliamsRobertR
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
337-48
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16117698-Adrenergic alpha-Agonists
,
pubmed-meshheading:16117698-Adrenergic beta-Antagonists
,
pubmed-meshheading:16117698-Adult
,
pubmed-meshheading:16117698-Aged
,
pubmed-meshheading:16117698-Aged, 80 and over
,
pubmed-meshheading:16117698-Double-Blind Method
,
pubmed-meshheading:16117698-Drug Combinations
,
pubmed-meshheading:16117698-Female
,
pubmed-meshheading:16117698-Glaucoma
,
pubmed-meshheading:16117698-Humans
,
pubmed-meshheading:16117698-Intraocular Pressure
,
pubmed-meshheading:16117698-Male
,
pubmed-meshheading:16117698-Middle Aged
,
pubmed-meshheading:16117698-Ocular Hypertension
,
pubmed-meshheading:16117698-Quinoxalines
,
pubmed-meshheading:16117698-Timolol
,
pubmed-meshheading:16117698-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
pubmed:affiliation
Glaucoma Consultants of Colorado, Littleton, CO, USA. ercraven@yahoo.com
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III